Literature DB >> 22200406

Capsaicin sensitizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: involvement of Ca(2+) influx.

Dong-Oh Moon1, Chang-Hee Kang, Sang-Hyuck Kang, Yung-Hyun Choi, Jin-Won Hyun, Weon-Young Chang, Hee-Kyoung Kang, Young-Sang Koh, Young-Hee Maeng, Young-Ree Kim, Gi-Young Kim.   

Abstract

Although tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in various malignant cells, several cancers including human hepatocellular carcinoma (HCC) exhibit potent resistance to TRAIL-induced cell death. The aim of this study is to evaluate the anti-cancer potential of capsaicin in TRAIL-induced cancer cell death. As indicated by assays that measure phosphatidylserine exposure, mitochondrial activity and activation of caspases, capsaicin potentiated TRAIL-resistant cells to lead to cell death. In addition, we found that capsaicin induces the cell surface expression of TRAIL receptor DR5, but not DR4 through the activation Sp1 on its promoter region. Furthermore, we investigated that capsaicin-induced DR5 expression and apoptosis are inhibited by calcium chelator or inhibitors for calmodulin-dependent protein kinase. Taken together, our data suggest that capsaicin sensitizes TRAIL-mediated HCC cell apoptosis by DR5 up-regulation via calcium influx-dependent Sp1 activation. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200406     DOI: 10.1016/j.taap.2011.12.010

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  15 in total

1.  A TRPV1-to-secretagogin regulatory axis controls pancreatic β-cell survival by modulating protein turnover.

Authors:  Katarzyna Malenczyk; Fatima Girach; Edit Szodorai; Petter Storm; Åsa Segerstolpe; Giuseppe Tortoriello; Robert Schnell; Jan Mulder; Roman A Romanov; Erzsébet Borók; Fabiana Piscitelli; Vincenzo Di Marzo; Gábor Szabó; Rickard Sandberg; Stefan Kubicek; Gert Lubec; Tomas Hökfelt; Ludwig Wagner; Leif Groop; Tibor Harkany
Journal:  EMBO J       Date:  2017-06-21       Impact factor: 11.598

2.  Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling.

Authors:  Su-Shan Zhang; Yu-Hao Ni; Chen-Ru Zhao; Zhen Qiao; Hong-Xia Yu; Lu-Yao Wang; Jin-Yan Sun; Chen Du; Jia-Hao Zhang; Li-Ying Dong; KeWei Wang; Jian-Jun Gao
Journal:  Acta Pharmacol Sin       Date:  2017-11-30       Impact factor: 6.150

Review 3.  An updated review on molecular mechanisms underlying the anticancer effects of capsaicin.

Authors:  Seok-Cheol Cho; Hyosung Lee; Bu Young Choi
Journal:  Food Sci Biotechnol       Date:  2017-02-28       Impact factor: 2.391

Review 4.  Concepts of oxidative stress and antioxidant defense in Crohn's disease.

Authors:  Mohammed A Alzoghaibi
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

5.  Proscillaridin A Sensitizes Human Colon Cancer Cells to TRAIL-Induced Cell Death.

Authors:  Manami Semba; Shinji Takamatsu; Sachiko Komazawa-Sakon; Eiji Miyoshi; Chiharu Nishiyama; Hiroyasu Nakano; Kenta Moriwaki
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

6.  TRAIL combinations: The new 'trail' for cancer therapy (Review).

Authors:  Alaa Refaat; Ahmed Abd-Rabou; Asmaa Reda
Journal:  Oncol Lett       Date:  2014-02-27       Impact factor: 2.967

7.  Effect of TRAIL in combination with DDP on the expression of MDR1 gene in gastric cancer cells.

Authors:  Yu-Fang Cui; Long-Shan Yu; Hui-Qun Wang; Ya-Wen Gou; Qiao-Ming Wang; Kai-Guang Zhang
Journal:  Prz Gastroenterol       Date:  2014-09-16

Review 8.  Capsaicin: Friend or Foe in Skin Cancer and Other Related Malignancies?

Authors:  Simona-Roxana Georgescu; Maria-Isabela Sârbu; Clara Matei; Mihaela Adriana Ilie; Constantin Caruntu; Carolina Constantin; Monica Neagu; Mircea Tampa
Journal:  Nutrients       Date:  2017-12-16       Impact factor: 5.717

9.  Silibinin sensitizes TRAIL-mediated apoptosis by upregulating DR5 through ROS-induced endoplasmic reticulum stress-Ca2+-CaMKII-Sp1 pathway.

Authors:  Matharage Gayani Dilshara; Rajapaksha Gedara Prasad Tharanga Jayasooriya; Ilandarage Menu Neelaka Molagoda; Jin-Woo Jeong; Seungheon Lee; Sang Rul Park; Gi-Young Kim; Yung Hyun Choi
Journal:  Oncotarget       Date:  2017-12-07

10.  A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase.

Authors:  Venturina Stagni; Simonetta Santini; Daniela Barilà
Journal:  Cancers (Basel)       Date:  2012-04-05       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.